| Gastrointestinal symptoms in a sample of children with pervasive developmental disorders RN Nikolov, KE Bearss, J Lettinga, C Erickson, M Rodowski, MG Aman, ... Journal of autism and developmental disorders 39 (3), 405-413, 2009 | 229 | 2009 |
| Gastrointestinal factors in autistic disorder: a critical review CA Erickson, KA Stigler, MR Corkins, DJ Posey, JF Fitzgerald, ... Journal of autism and developmental disorders 35 (6), 713, 2005 | 203 | 2005 |
| Antipsychotics in the treatment of autism DJ Posey, KA Stigler, CA Erickson, CJ McDougle The Journal of clinical investigation 118 (1), 6-14, 2008 | 188 | 2008 |
| A retrospective study of memantine in children and adolescents with pervasive developmental disorders CA Erickson, DJ Posey, KA Stigler, J Mullett, AR Katschke, CJ McDougle Psychopharmacology 191 (1), 141-147, 2007 | 150 | 2007 |
| Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders CJ McDougle, KA Stigler, CA Erickson, DJ Posey Journal of Clinical Psychiatry 69, 15, 2008 | 140 | 2008 |
| Neurochemistry in the pathophysiology of autism CJ McDougle, CA Erickson, KA Stigler, DJ Posey Journal of Clinical Psychiatry 66, 9, 2005 | 130 | 2005 |
| Aggression in autism spectrum disorder: presentation and treatment options. SE Fitzpatrick, L Srivorakiat, LK Wink, EV Pedapati, CA Erickson Dove Medical Press Ltd., 2016 | 114 | 2016 |
| STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study CA Erickson, JM Veenstra-Vanderweele, RD Melmed, JT McCracken, ... Journal of autism and developmental disorders 44 (4), 958-964, 2014 | 99 | 2014 |
| Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study KA Stigler, JT Diener, AE Kohn, L Li, CA Erickson, DJ Posey, ... Journal of child and adolescent psychopharmacology 19 (3), 265-274, 2009 | 95 | 2009 |
| Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome CA Erickson, LK Wink, B Ray, MC Early, E Stiegelmeyer, ... Psychopharmacology 228 (1), 75-84, 2013 | 88 | 2013 |
| The use of selective serotonin reuptake inhibitors in autism and related disorders DJ Posey, CA Erickson, KA Stigler, CJ McDougle Journal of Child & Adolescent Psychopharmacology 16 (1-2), 181-186, 2006 | 82 | 2006 |
| Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders LK Wink, CA Erickson, CJ McDougle Current Treatment Options in Neurology 12 (6), 529-538, 2010 | 79 | 2010 |
| Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study BA Adler, LK Wink, M Early, R Shaffer, N Minshawi, CJ McDougle, ... Autism 19 (1), 102-106, 2015 | 77 | 2015 |
| SPARK: a US cohort of 50,000 families to accelerate autism research P Feliciano, AM Daniels, LAG Snyder, A Beaumont, A Camba, A Esler, ... Neuron 97 (3), 488-493, 2018 | 75 | 2018 |
| Diagnosing autism spectrum disorder from brain resting-state functional connectivity patterns using a deep neural network with a novel feature selection method X Guo, KC Dominick, AA Minai, H Li, CA Erickson, LJ Lu Frontiers in neuroscience 11, 460, 2017 | 75 | 2017 |
| Brief report: acamprosate in fragile X syndrome CA Erickson, JE Mullett, CJ McDougle Journal of autism and developmental disorders 40 (11), 1412-1416, 2010 | 74 | 2010 |
| Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole LK Wink, M Early, T Schaefer, A Pottenger, P Horn, CJ McDougle, ... Journal of child and adolescent psychopharmacology 24 (2), 78-82, 2014 | 73 | 2014 |
| Developing drugs for core social and communication impairment in autism DJ Posey, CA Erickson, CJ McDougle Child and adolescent psychiatric clinics of North America 17 (4), 787-801, 2008 | 73 | 2008 |
| Open-label riluzole in fragile X syndrome CA Erickson, N Weng, IJ Weiler, WT Greenough, KA Stigler, LK Wink, ... Brain research 1380, 264-270, 2011 | 70 | 2011 |
| Updated report on tools to measure outcomes of clinical trials in fragile X syndrome DB Budimirovic, E Berry-Kravis, CA Erickson, SS Hall, D Hessl, AL Reiss, ... Journal of Neurodevelopmental Disorders 9 (1), 1-36, 2017 | 68 | 2017 |
